<UMA 98-04>A New Vaccine for Protection of Children and Adults Against Schistosomiasis

The Portal is a joint project of MATTO and the MTTC. The development and implementation of the portal has been paid for by the MTTC, Beth Israel Deaconess Medical Center, Boston Biomedical Research Institute, Boston University, Brandeis University, Caritas St. Elizabeth's Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Northeastern University, The Schepens Eye Research Institute, and Tufts University.

Intellectual Property

ID:		UMA 98-04
IP Type:		Licensable Technology
Title:		A New Vaccine for Protection of Children and Adults Against Schistosomiasis
Inventor:		Lloyd H. Semprevivo
Summary:		A new vaccine has been developed that has the potential to protect children and adults from Schistosomiasis. Now demonstrated in laboratory mice to show 100% protection against a virulent challenge by 100 parasites.
Tech Type:		Therapeutics - Drugs and Vaccines \| Research Tools \| Therapeutics - Drugs and Vaccines \| Research Tools
URL:		http://amherst.cvip-umass.net/index.cfm?fuseaction=tech.index
Contact:		Office of Commercial Ventures and Intellectual Property Phone: 413-545-3606 FAX: 413-545-3632 E-Mail: cvip@research.umass.edu
Organization:		University of Massachusetts at Amherst

Display all intellectual properties for Lloyd H. Semprevivo
Display all intellectual properties for University of Massachusetts at Amherst